Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 2:39 pm Sale | 13G | Research Alliance Corp. II RACB | PERCEPTIVE ADVISORS LLC | 0 0.000% | -1,000,000 (Position Closed) | View |
| 2023-02-14 2:18 pm Sale | 13G | Research Alliance Corp. II RACB | Alyeska Investment Group L.P. | 0 0.000% | -800,000 (Position Closed) | View |
| 2023-02-14 07:41 am Sale | 13G | Research Alliance Corp. II RACB | CITADEL ADVISORS LLC | 0 0.000% | -944,497 (Position Closed) | View |
| 2023-02-14 06:16 am Sale | 13G | Research Alliance Corp. II RACB | HealthCor Management L.P. | 0 0.000% | -1,324,800 (Position Closed) | View |
| 2023-02-08 5:16 pm Sale | 13G | Research Alliance Corp. II RACB | Laurion Capital Management LP | 0 0.000% | -800,000 (Position Closed) | View |
| 2023-01-10 2:29 pm Sale | 13G | Research Alliance Corp. II RACB | First Trust Capital Management L.P. | 0 0.000% | -1,820,422 (Position Closed) | View |
| 2022-11-10 11:32 am Purchase | 13G | Research Alliance Corp. II RACB | First Trust Capital Management L.P. | 1,820,422 11.780% | 1,820,422 (New Position) | View |
| 2022-11-02 08:40 am Sale | 13G | Research Alliance Corp. II RACB | Saba Capital Management L.P. | 0 0.000% | -1,950,574 (Position Closed) | View |
| 2022-06-15 1:16 pm Purchase | 13G | Research Alliance Corp. II RACB | Saba Capital Management L.P. | 1,950,574 12.600% | 1,950,574 (New Position) | View |
| 2022-02-14 5:15 pm Unchanged | 13G | Research Alliance Corp. II RACB | PERCEPTIVE ADVISORS LLC | 1,000,000 6.500% | 0 (Unchanged) | View |
| 2022-02-14 3:28 pm Purchase | 13G | Research Alliance Corp. II RACB | Alyeska Investment Group L.P. | 800,000 5.180% | 800,000 (New Position) | View |
| 2022-02-14 10:35 am Purchase | 13G | Research Alliance Corp. II RACB | HealthCor Management L.P. | 1,324,800 8.600% | 324,800 (+32.48%) | View |
| 2022-02-14 06:12 am Sale | 13G | Research Alliance Corp. II RACB | CITADEL ADVISORS LLC | 944,497 6.100% | -11,372 (-1.19%) | View |
| 2022-02-09 5:21 pm Purchase | 13G | Research Alliance Corp. II RACB | Sculptor Capital LP | 789,870 5.110% | 789,870 (New Position) | View |
| 2022-01-31 6:23 pm Purchase | 13G | Research Alliance Corp. II RACB | Laurion Capital Management LP | 800,000 5.200% | 800,000 (New Position) | View |
| 2021-04-01 4:05 pm Purchase | 13G | Research Alliance Corp. II RACB | CITADEL ADVISORS LLC | 955,869 6.200% | 955,869 (New Position) | View |
| 2021-03-29 4:03 pm Purchase | 13G | Research Alliance Corp. II RACB | HealthCor Management L.P. | 1,000,000 6.500% | 1,000,000 (New Position) | View |
| 2021-03-26 5:00 pm Purchase | 13G | Research Alliance Corp. II RACB | PERCEPTIVE ADVISORS LLC | 1,000,000 6.000% | 1,000,000 (New Position) | View |